Home Tags MabPlex

Tag: MabPlex

Rapidly Expanding MabPlex International Secures U.S. $ 59.1 Million Series A...

In an announcement made to the international business and financial press, MabPlex International, a global Contract Development and Manufacturing Organization or CDMO based in...
MabPlex

MabPlex’s Manufactured Monoclonal Antibody Receives IND Approval from the U.S. Food...

Leading Contract Development and Manufacturing Organization (CDMO) MabPlex International, serving the global biopharmaceutical and biotechnology industries with sites in China and the United States,...

MabPlex Opens New Phase III and Commercial Manufacturing Facility

MabPlex International, a fully integrated Contract Development and Manufacturing Organization (CDMO) with sites in China and the United States, has inaugurated their new manufacturing...

Benefitting from the Worldwide Supply Chain in the development of Antibody-drug...

Timing is everything. Just over a decade ago, the pharmaceutical industry and R&D in China was dominated by generics and plagued with insufficient technical capacity...
Scientist pipetting

Researchers Develop Novel anti-CD19 Antibody-drug Conjugates for the Treatment of B-cell...

In an article published in July 2018 edition of the International Immunopharmacology researchers and scientists from RemeGen (Yantai 264006, Shandong, China) and Mabplex International...
MabPlex Building

Andrew Huang: “ADC’s Are Among the most Powerful Options to...

With a population of 1.4 billion and a rapidly expanding economy, China has become a manufacturing powerhouse. In addition, China is pursuing a...

MabPlex

MabPlex, founded in 2013, is a specialized, global CRO/CMO service provider, offering one-stop biologics development and manufacturing solutions to customers with a services from...

FEATURED